Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zevra Therapeutics, Inc. - Common Stock
(NQ:
ZVRA
)
4.520
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
157,431
Open
4.520
Bid (Size)
4.520 (4)
Ask (Size)
4.530 (39)
Prev. Close
4.520
Today's Range
4.480 - 4.600
52wk Range
3.890 - 7.280
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ZEVRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Zevra Therapeutics, Inc. on Behalf of Zevra Stockholders and Encourages Investors to Contact the Firm
April 03, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zevra Therapeutics, Inc. (ZVRA)
April 02, 2024
From
Kirby McInerney LLP
Via
GlobeNewswire
Performance
YTD
-33.82%
-33.82%
1 Month
-23.91%
-23.91%
3 Month
-24.35%
-24.35%
6 Month
+4.15%
+4.15%
1 Year
-13.24%
-13.24%
More News
Read More
ZVRA Stock Earnings: Zevra Therapeutics Misses EPS, Beats Revenue for Q4 2023
March 28, 2024
Via
InvestorPlace
Zevra Therapeutics: Q4 Earnings Insights
March 28, 2024
Via
Benzinga
Earnings Outlook For Zevra Therapeutics
March 27, 2024
Via
Benzinga
Zevra Therapeutics's Earnings: A Preview
November 06, 2023
Via
Benzinga
Zevra Therapeutics's Earnings: A Preview
August 11, 2023
Via
Benzinga
Earnings Scheduled For March 28, 2024
March 28, 2024
Via
Benzinga
Microsoft To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Thursday
December 28, 2023
Via
Benzinga
A Preview Of Zevra Therapeutics's Earnings
May 12, 2023
Via
Benzinga
Earnings Preview: Zevra Therapeutics
March 06, 2023
Via
Benzinga
BioMedNewsBreaks – Zevra Therapeutics Inc. (NASDAQ: ZVRA) Resubmits Arimoclomol New Drug Application to the FDA
December 27, 2023
Via
Investor Brand Network
Exposures
Product Safety
InvestorNewsBreaks — Zevra Therapeutics Inc. (NASDAQ: ZVRA) Names New President, CEO and Director
October 10, 2023
Via
Investor Brand Network
Topics
Retirement
Exposures
Pension
Health Care Company Zevra Therapeutics Announces Merger With Acer Therapeutics
August 31, 2023
Via
Benzinga
Why Is Acer Therapeutics Stock Trading Higher Today?
August 31, 2023
Via
Benzinga
Earnings Scheduled For November 7, 2023
November 07, 2023
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq -
August 31, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Why Is Acer Therapeutics (ACER) Stock Up 85% Today?
August 31, 2023
Via
InvestorPlace
Citius Pharmaceuticals Approaches End Of Trial For Catheter-Related Bloodstream Infections – How Are Analysts Scoring Its Stock?
May 04, 2023
Via
Benzinga
Earnings Scheduled For August 14, 2023
August 14, 2023
Via
Benzinga
Earnings Scheduled For May 15, 2023
May 15, 2023
Via
Benzinga
Over $7M Bet On This Consumer Defensive Stock? Check Out These 4 Penny Stocks Insiders Are Buying
March 16, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
March 17, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 07, 2023
Via
Benzinga
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 07, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.